Genomics and proteomics -: the way forward

被引：18

作者：

Baak, JPA ^{[1
]}

Janssen, EAM

Soreide, K

Heikkilæ, R

机构：

[1] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway

[2] Stavanger Univ Hosp, Dept Med Hemtooncol, Stavanger, Norway

[3] Univ Bergen, Gade Inst, N-5020 Bergen, Norway

[4] Free Univ Amsterdam, Amsterdam, Netherlands

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷

关键词：

D O I：

10.1093/annonc/mdi728

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：30 / 44

页数：15

共 106 条

[51] Lessons from hereditary colorectal cancer [J].

Kinzler, KW ;

Vogelstein, B .

CELL, 1996, 87 (02) :159-170

[52] MUTATION AND CANCER - STATISTICAL STUDY OF RETINOBLASTOMA [J].

KNUDSON, AG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (04) :820-&

[53]

KRISHNA RG, 1988, PROTEINS ANAL DESIGN, P121

[54] Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: Role of markers of proliferative activity and differentiation and Rb availability [J].

Kruse, AJ ;

Skaland, I ;

Janssen, EA ;

Buhr-Wildhagen, S ;

Klos, J ;

Arends, MJ ;

Baak, JPA .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (02) :100-109

[55] Effect of re-treatment with gefitinib ('Iressa', ZD1839) after acquisition of resistance [J].

Kurata, T ;

Tamura, K ;

Kaneda, H ;

Nogami, T ;

Uejima, H ;

Asai, G ;

Nakagawa, K ;

Fukuoka, M .

ANNALS OF ONCOLOGY, 2004, 15 (01) :173-174

[56] HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization - A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring [J].

Lal, P ;

Salazar, PA ;

Hudis, CA ;

Ladanyi, M ;

Chen, BY .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (05) :631-636

[57] Initial sequencing and analysis of the human genome [J].

Lander, ES ;

Int Human Genome Sequencing Consortium ;

Linton, LM ;

Birren, B ;

Nusbaum, C ;

Zody, MC ;

Baldwin, J ;

Devon, K ;

Dewar, K ;

Doyle, M ;

FitzHugh, W ;

Funke, R ;

Gage, D ;

Harris, K ;

Heaford, A ;

Howland, J ;

Kann, L ;

Lehoczky, J ;

LeVine, R ;

McEwan, P ;

McKernan, K ;

Meldrim, J ;

Mesirov, JP ;

Miranda, C ;

Morris, W ;

Naylor, J ;

Raymond, C ;

Rosetti, M ;

Santos, R ;

Sheridan, A ;

Sougnez, C ;

Stange-Thomann, N ;

Stojanovic, N ;

Subramanian, A ;

Wyman, D ;

Rogers, J ;

Sulston, J ;

Ainscough, R ;

Beck, S ;

Bentley, D ;

Burton, J ;

Clee, C ;

Carter, N ;

Coulson, A ;

Deadman, R ;

Deloukas, P ;

Dunham, A ;

Dunham, I ;

Durbin, R ;

French, L .

NATURE, 2001, 409 (6822) :860-921

[58] CANCER - P53, GUARDIAN OF THE GENOME [J].

LANE, DP .

NATURE, 1992, 358 (6381) :15-16

[59] PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas [J].

Lee, JW ;

Soung, YH ;

Kim, SY ;

Lee, HW ;

Park, WS ;

Nam, SW ;

Kim, SH ;

Lee, JY ;

Yoo, NJ ;

Lee, SH .

ONCOGENE, 2005, 24 (08) :1477-1480

[60]

Levine AJ, 2004, CELL, V116, pS69

← 1 2 3 4 5 6 7 8 9 10 →